trending Market Intelligence /marketintelligence/en/news-insights/trending/xutwqvvwwg4unnbih0zzvq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medartis raises CHF142.6M in IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Medartis raises CHF142.6M in IPO

Medartis Holding AG completed its previously announced IPO, raising CHF142.6 million in gross proceeds.

The Swiss healthcare equipment manufacturer issued 2,994,791 new shares priced CHF48 apiece, including 390,625 stocks that were sold as part of the offering's overallotment option granted to underwriters.

Zürcher Kantonalbank and Bryan Garnier & Co. were acting as underwriters, joint global coordinators and joint book runners for the planned IPO, with Kepler Cheuvreux serving as underwriter and co-manager.

Quarton International acted as financial adviser to the company.

Medartis founder and Chairman Thomas Straumann remains the largest shareholder of the company with a stake of 47.9%.

Vice Chairman Dominik Ellenrieder owns a 7.9% stake, while Medartis co-founder and CEO Willi Miesch owns 6%.

The free float amounts to 24.6%, not comprising the shares that are subject to a 12-month lock-up.